Tada T - Search Results

1

MARCH8 inhibits viral infection by two different mechanisms.

Zhang Y, Tada T, Ozono S, Kishigami S, Fujita H, Tokunaga K. Zhang Y, et al. Among authors: tada t. Elife. 2020 Aug 11;9:e57763. doi: 10.7554/eLife.57763. Elife. 2020. PMID: 32778221 Free PMC article.

2

Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cells.

Tada T, Kadoki M, Liu Y, Tokunaga K, Iwakura Y. Tada T, et al. Front Microbiol. 2013 Dec 17;4:377. doi: 10.3389/fmicb.2013.00377. eCollection 2013. Front Microbiol. 2013. PMID: 24381568 Free PMC article.

3

Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.

Kikuchi T, Iwabu Y, Tada T, Kawana-Tachikawa A, Koga M, Hosoya N, Nomura S, Brumme ZL, Jessen H, Pereyra F, Trocha A, Walker BD, Iwamoto A, Tokunaga K, Miura T. Kikuchi T, et al. Among authors: tada t. J Virol. 2015 May;89(9):4992-5001. doi: 10.1128/JVI.03464-14. Epub 2015 Feb 25. J Virol. 2015. PMID: 25717111 Free PMC article.

4

MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.

Tada T, Zhang Y, Koyama T, Tobiume M, Tsunetsugu-Yokota Y, Yamaoka S, Fujita H, Tokunaga K. Tada T, et al. Nat Med. 2015 Dec;21(12):1502-7. doi: 10.1038/nm.3956. Epub 2015 Nov 2. Nat Med. 2015. PMID: 26523972

5

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection.

Zhang Y, Tada T, Ozono S, Yao W, Tanaka M, Yamaoka S, Kishigami S, Fujita H, Tokunaga K. Zhang Y, et al. Among authors: tada t. J Biol Chem. 2019 Mar 8;294(10):3397-3405. doi: 10.1074/jbc.AC118.005907. Epub 2019 Jan 10. J Biol Chem. 2019. PMID: 30630952 Free PMC article.

6

MARCH8: the tie that binds to viruses.

Tada T, Zhang Y, Fujita H, Tokunaga K. Tada T, et al. FEBS J. 2022 Jul;289(13):3642-3654. doi: 10.1111/febs.16017. Epub 2021 May 31. FEBS J. 2022. PMID: 33993615 Free article. Review.

7

MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.

Zhang Y, Ozono S, Tada T, Tobiume M, Kameoka M, Kishigami S, Fujita H, Tokunaga K. Zhang Y, et al. Among authors: tada t. Microbiol Spectr. 2022 Feb 23;10(1):e0061821. doi: 10.1128/spectrum.00618-21. Epub 2022 Jan 12. Microbiol Spectr. 2022. PMID: 35019698 Free PMC article.

8

Further Characterization of the Antiviral Transmembrane Protein MARCH8.

Tada T, Zhang Y, Kong D, Tanaka M, Yao W, Kameoka M, Ueno T, Fujita H, Tokunaga K. Tada T, et al. Cells. 2024 Apr 17;13(8):698. doi: 10.3390/cells13080698. Cells. 2024. PMID: 38667313 Free PMC article.

9

Directly injected lentiviral vector-based T cell vaccine protects mice against acute and chronic viral infection.

Tada T, Norton TD, Leibowitz R, Landau NR. Tada T, et al. JCI Insight. 2022 Sep 22;7(18):e161598. doi: 10.1172/jci.insight.161598. JCI Insight. 2022. PMID: 35972807 Free PMC article.

10

Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection.

Norton TD, Tada T, Leibowitz R, van der Heide V, Homann D, Landau NR. Norton TD, et al. Among authors: tada t. Mol Ther. 2020 Aug 5;28(8):1795-1805. doi: 10.1016/j.ymthe.2020.05.018. Epub 2020 May 20. Mol Ther. 2020. PMID: 32497512 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,702 results

Search Page

Filters